Literature DB >> 2888823

Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin.

R D Pearson1, P Symes, M Conboy, A A Weiss, E L Hewlett.   

Abstract

Bordetella pertussis and the other Bordetella species produce a novel adenylate cyclase toxin which enters target cells to catalyze the production of supraphysiologic levels of intracellular cyclic adenosine monophosphate (cAMP). In these studies, dialyzed extracts from B. pertussis containing the adenylate cyclase toxin, a partially purified preparation of adenylate cyclase toxin, and extracts from transposon Tn5 mutants of B. pertussis lacking the adenylate cyclase toxin, were used to assess the effects of adenylate cyclase toxin on human peripheral blood monocyte activities. Luminol-enhanced chemiluminescence of monocytes stimulated with opsonized zymosan was inhibited greater than 96% by exposure to adenylate cyclase toxin-containing extract, but not by extracts from adenylate cyclase toxin-deficient mutants. The chemiluminescence responses to particulate (opsonized zymosan, Leishmania donovani, and Staphylococcus aureus) and soluble (phorbol myristate acetate) stimuli were inhibited equivalently. The superoxide anion generation elicited by opsonized zymosan was inhibited 92% whereas that produced by phorbol myristate acetate was inhibited only 32% by B. pertussis extract. Inhibition of oxidative activity was associated with a greater than 500-fold increase in monocyte cAMP levels, but treated monocytes remained viable as assessed by their ability to exclude trypan blue and continued to ingest particulate stimuli. The major role of the adenylate cyclase toxin in the inhibition of monocyte oxidative responses was demonstrated by: 1) little or no inhibition by extracts from B. pertussis mutants lacking adenylate cyclase toxin; 2) high level inhibition with extract from B. parapertussis, a related species lacking pertussis toxin; and 3) a reciprocal relationship between monocyte cAMP levels and inhibition of opsonized zymosan-induced chemiluminescence using both crude extract and partially purified adenylate cyclase toxin. Pertussis toxin, which has been shown to inhibit phagocyte responses to some stimuli by a cAMP-independent mechanism, had only a small (less than 20%) inhibitory effect when added at concentrations up to 100-fold in excess of those present in B. pertussis extract. These data provide strong support for the hypothesis that B. pertussis adenylate cyclase toxin can increase cAMP levels in monocytes without compromising target cell viability or impairing ingestion of particles and that the resultant accumulated cAMP is responsible for the inhibition of oxidative responses to a variety of stimuli.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Role of CD11b/CD18 in the process of intoxication by the adenylate cyclase toxin of Bordetella pertussis.

Authors:  Joshua C Eby; Mary C Gray; Annabelle R Mangan; Gina M Donato; Erik L Hewlett
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.

Authors:  Pádraig J Ross; Ed C Lavelle; Kingston H G Mills; Aoife P Boyd
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 4.  Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.

Authors:  Jiri Masin; Radim Osicka; Ladislav Bumba; Peter Sebo
Journal:  Pathog Dis       Date:  2015-09-20       Impact factor: 3.166

5.  The RNA chaperone Hfq is required for virulence of Bordetella pertussis.

Authors:  Ilona Bibova; Karolina Skopova; Jiri Masin; Ondrej Cerny; David Hot; Peter Sebo; Branislav Vecerek
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

6.  Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry.

Authors:  M C Gray; W Ross; K Kim; E L Hewlett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  In vitro and in vivo studies of macrophage functions in amebiasis.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.